Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 4/20 | 0.49 |
| ▸ | PSMB8 | P28062 | 3/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | FCER2 | P06734 | 1/20 | 0.42 |
| ▸ | REN | P00797 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5966627 | 0.91 | MMP1 (0.48) | CTSLMMP1FCER2EPHX2 | |
| SCHEMBL5966579 | 0.86 | PSMB5 (0.46) | PSMB5PSMB8SIGMAR1F2CTSL | |
| SCHEMBL5966704 | 0.84 | GNPAT (0.50) | CTSLMMP1 | |
| SCHEMBL5966616 | 0.84 | GNPAT (0.50) | CTSLMMP1 | |
| SCHEMBL5966623 | 0.84 | GNPAT (0.50) | CTSLMMP1 | |
| SCHEMBL16899187 | 0.79 | PSMB5 (0.65) | PSMB5PSMB8SIGMAR1MMP1FCER2 | |
| SCHEMBL16899266 | 0.79 | PSMB5 (0.65) | PSMB5PSMB8SIGMAR1MMP1FCER2 | |
| SCHEMBL5966647 | 0.79 | CTSL (0.40) | PSMB5PSMB8SIGMAR1F2CTSL | |
| SCHEMBL7370024 | 0.78 | PSMB5 (0.46) | PSMB5HRH4 | |
| SCHEMBL16899184 | 0.76 | PSMB8 (0.64) | PSMB5PSMB8SIGMAR1F2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | THE PROCTER & GAMBLE COMPANY | 2006-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | MC3R, MC4R, MC1R | PSMB5 2300/4885PSMB8 2455/4885SIGMAR1 543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.